Australia markets closed
  • ALL ORDS

    7,562.50
    -37.40 (-0.49%)
     
  • AUD/USD

    0.7157
    +0.0029 (+0.41%)
     
  • ASX 200

    7,239.80
    -39.50 (-0.54%)
     
  • OIL

    71.56
    +3.41 (+5.00%)
     
  • GOLD

    1,796.60
    +8.50 (+0.48%)
     
  • BTC-AUD

    79,779.12
    +3,081.10 (+4.02%)
     
  • CMC Crypto 200

    1,428.58
    -26.83 (-1.84%)
     

Treatment's Global Library of Medicine Expands to Singapore

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

VANCOUVER, British Columbia, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE), (OTC: TREIF), a healthcare AI technology company, has expanded the reach of Global Library of Medicine (GLM) into Singapore, signaling its first entry into Southeast Asia. Treatment’s GLM is the world’s most advanced medical database, and the platform for a new category of tools in healthcare delivery.

The Global Library of Medicine’s consortium of doctors now includes more than 50 members across four continents, with some of its newest members practicing in Singapore. “When we expand the number of doctors and the number of countries participating in the development of our AI-driven database, we greatly increase our ability to offer a global solution to the problem of delivering improved patient safety, cost of care, prevention, and overall healthcare outcomes,” says Dr. Kevin A. Peterson, MD, MPH, FRCS(Ed), FAAFP and Chief Medical Officer of Treatment.

The GLM’s architecture includes detailed knowledge of hundreds of complex disease presentations, physical signs, pathology, anatomy, laboratory and x-ray findings, as well as detailed descriptions of where diseases are most likely to occur, how they are transmitted, and who is at the greatest risk. The multi-layered, multi-modular design of this extensive platform provides a medical value exchange to consumers, clinicians, and commercial users.

Treatment’s much anticipated first product, Cara, is a virtual assistant that will leverage Treatment’s GLM and AI engine, and be available to consumers through a mobile app which will be released this year.

About Treatment.com

Treatment.com is a disruptive healthcare technology company that is harnessing the power of AI to help global citizens improve their health through personalized recommendations and insights. Based in Vancouver with a US subsidiary, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the parent company of Treatment Mobile, and Cara, an intelligent digital health assistant which will empower people to take control of their health through an innovative mobile app, powered by Treatment’s exclusive AI engine.

For more investor information on Treatment.com please visit https://treatment.com/investors/.

Forward Looking Statement

This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

For more information:

Investor Contact: investors@treatment.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting